Last reviewed · How we verify
NCT06716229: NutPeBol
Relationship of Nutritional Support for Critically Ill Children With Clinical Outcomes in a Pediatric Hospital in Bolivia (NutPeBol)
trial in Critically Ill Children in 56 participants. Not yet recruiting.
28 November 2025
Quick facts
| Lead sponsor | MPH D Raul Copana-Olmos |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 56 |
| Start date | 6 April 2025 |
| Primary completion | 28 November 2025 |
| Estimated completion | 19 December 2025 |
| Sites | 2 locations across Bolivia |
Conditions studied
- Critically Ill Children — all drugs for Critically Ill Children →
- Nutritional Support — all drugs for Nutritional Support →
Sponsor
MPH D Raul Copana-Olmos
Who can join
Adults 1 Month to 15, any sex, with Critically Ill Children or Nutritional Support. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this observational study is to learn about the characteristics of nutritional support in critically ill children. The primary question to be answered is Is there an association between nutritional support of the critically ill child and clinical and hospital outcomes in children admitted to a pediatric referral center? Patients will be followed throughout their hospitalization, with a step-by-step evaluation of the nutritional support received through standard care and a review of the results obtained in the patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06716229
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06716229 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MPH D Raul Copana-Olmos
- Last refreshed: 14 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06716229.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing